NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Johnson & Johnson (China) Investment Ltd.
Conditions: Lung Neoplasms, Pulmonary Disease, Chronic Obstructive
Interventions: No intervention
Countries: China
The purpose of this study is to assess the current smoking status and smoking cessation attempts among smokers or recent smoking quitters during the perioperative period, to describe postoperative pulmonary complications (PPCs) and other postoperative complications (PCs) following a lung surgery, and to describe the smoking cessation methods and services patients received from their health care professionals (HCPs) and participant's satisfaction among participants with lung cancer, chronic obstructive pulmonary disorder (COPD), a pulmonary lesion (example, nodule, or ground glass opacity) or other pulmonary conditions who are admitted to the thoracic surgical unit of the participating hospitals in China.
Sex: ALL
Age: 40 Years to 80 Years
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Participants who have been scheduled for an elective lung surgery by the treating physician's judgement, due to the following conditions: known lung cancer, COPD, a pulmonary lesion (example. nodule, ground glass opacity) or other pulmonary conditions * Smokers who are or were smoking on average no fewer than 5 cigarettes per day for equal or more than 3 years within 3 months prior to the scheduled surgery, or recent smoking quitters with a history of smoking on average no fewer than 5 cigarettes per day for equal or more than 3 years, who quit smoking between 3 months and 5 years prior to the scheduled surgery * Being willing to participate the study and sign the participant informed consent form (ICF) Exclusion Criteria: * Participants who have emergency lung surgery due to accident or injury * Participants are not likely to be able to complete the 6-month follow-up after the lung surgery
- Beijing, China
- Guangzhou, China
- Shanghai, China